4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0001104659-24-050577
Options or other derivatives
- Director acquired 28,587 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Peterson Kristine Director | 2024-04-22 | Grant or award · Stock Option (right to buy) | +28,587 | 28,587 | D | ||
Loading xslF345X05/tm2412470-2_4seq1.xml…